Objective: To measure changes in undiagnosed HIV among gay and bisexual men (GBM) in Melbourne.
U ndiagnosed HIV is recognised as a key driver of HIV epidemics among gay, bisexual and other men who have sex with men (GBM). Correct knowledge of one's HIV status provides the foundation for effective seroadapative HIV prevention practices, 1 and timely diagnosis allows postdiagnosis mitigation of risk behaviour, 2 and prevention of onward transmission through early treatment and subsequent reduction in HIV viral load. 3 Mathematical modelling of HIV epidemics in developed countries suggests a grossly disproportionate contribution of undiagnosed HIV to transmissions among GBM. Modelling of the Australian HIV epidemic has previously reported that the nine percent of GBM living with HIV who were estimated to be undiagnosed contributed to 30% of new infections. 4 More recent modelling in Europe suggests that undiagnosed GBM contribute up to 70% of new HIV infections. 5, 6 The putative contribution of undiagnosed HIV to onward transmission has led to the establishment of HIV prevention targets that focus on reducing undiagnosed HIV prevalence in specific risk populations. 7, 8 The monitoring of such targets requires the periodic assessment of undiagnosed HIV, either through modelling or direct measurement in community-recruited samples. Models can be relatively easily revised periodically using updated surveillance data, albeit with inherent limitations associated with parameter uncertainties. 9 Only a limited number of studies have directly measured changes in undiagnosed HIV over time in communityrecruited samples. Behavioural surveillance among GBM in San Francisco between 2004 and 2011 showed significant declines in undiagnosed HIV prevalence (from 21.7% to 7.5%) and non-significant declines in community viral load coinciding with increases in HIV testing. 10, 11 In Baltimore, very COUNT provides the first study of trends in undiagnosed HIV among GBM in Australia.
Here we compare the findings from the Melbourne sample of the COUNT study with findings from the previous Melbourne study of undiagnosed HIV in GBM.
Methods

Suck It & See (SIAS)
The methods for SIAS have been described in detail elsewhere. 15 
Statistical analysis
We compared differences in HIV prevalence outcomes (serological prevalence, rates of self-reported previous HIV diagnosis and proportion of undiagnosed HIV) between the SIAS and the overall COUNT samples and by COUNT participation types (anonymous vs. confidential) and COUNT participants recruited at sex and social gay venues (to compare similarly recruited samples) using two-sample tests of proportions. Proportion of undiagnosed HIV was calculated as a proportion of men with HIV-positive test results among those who indicated they were HIV-negative, untested or of unknown HIV status. Participant characteristics (age, country of birth, education, employment status, HIV testing history and sexual risk behaviours) were also compared between the overall SIAS and COUNT samples and by COUNT participation types and participants recruited through sex and social venues. Data management and analysis was conducted using Stata 13.1. 21 Statistical significance was set at p<0.05.
Results
The 639 SIAS participants were recruited exclusively through sex and social venues, 275 (43%) in gay bars or dance clubs and 364 (57%) in SOPVs. A total of 993 GBM were recruited in Melbourne for the COUNT study, 755 (76%) at the Midsumma
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community festival and 238 (24%) through gay community sex and social venues. Of the participants recruited into COUNT through sex and social venues, 149 (63%) were recruited at gay bars or dance clubs and 89 (37%) at SOPVs. Table 1 compares HIV prevalence in SIAS with all COUNT participants, those participating anonymously (consistent with SIAS) and participating confidentially (opting to receive results; inconsistent with SIAS), and those recruited in sex and social venues only (consistent with SIAS). Serological HIV prevalence was 9.1% in SIAS and 7.1% in COUNT. The proportion of participants reporting a previous HIV diagnosis was identical (6.6%) between samples, but the proportion classified as having an undiagnosed HIV infection was significantly higher in SIAS (3.0%) than in COUNT (0.5%). A significant difference in undiagnosed HIV was detected between SIAS (31.1%) and the overall COUNT sample (7.1%). Undiagnosed HIV was higher among COUNT participants recruited in sex and social venues (17.6%) and not significantly different from the venuerecruited SIAS sample. Undiagnosed HIV was also higher among confidential (25.0%) compared to anonymous participants (1.9%).
The characteristics of anonymous and confidential COUNT participants were broadly similar, and comparisons between SIAS and overall COUNT participants broadly reflect comparisons with confidential and anonymous COUNT participants. Table  2 compares the characteristics of SIAS participants, overall COUNT participants and those recruited at sex and social venues, consistent with SIAS. SIAS participants were, on average, older than COUNT participants and more likely to be employed, but were similar in relation to country of birth and education. A greater proportion of SIAS participants (23.0%) reported no prior HIV testing compared with COUNT participants (11.6%), although similar proportions reported testing in the past 12 months.
The sexual behaviours reported by COUNT participants overall were indicative of a lower risk profile compared with SIAS participants; lower proportions reported sex with casual partners (although the proportion reporting condomless sex with casual partners was similar), group sex or sex with more than 10 partners in the past six months, while a greater proportion reported having a regular sex partner. However, COUNT participants recruited from sex and social venues were more similar to SIAS participants; sexual behaviour and risk were largely similar, with the exception of lower proportions reporting group sex in the past six months and a higher proportion reporting lifetime HIV testing.
Discussion
Findings from this study suggest a decline in the prevalence of undiagnosed HIV among GBM 29 Indeed, recent modelling of concurrent changes in HIV and hepatitis C incidence among people who inject drugs in Vancouver have suggested a relatively modest impact of increasing ART coverage on HIV prevention in this population. 30 There remain concerns that 90-90-90 targets may be insufficient to drive the inferred declines in HIV incidence, 31 especially in settings where testing, treatment and viral suppression coverage is already high. 32 (32) . Australia is among the countries in the world closest to achieving these UNAIDS targets, 33 and current estimates of the care cascade in Victoria suggests an undiagnosed HIV prevalence at 10% (an estimate that sits between the prevalence of undiagnosed HIV detected in the overall COUNT sample and among venuerecruited GBM) based on statistical backprojection methods. 29 The most important limitation of our comparative analyses relates to differences in study protocols and recruitment locations between studies. In our study, we disaggregated findings from COUNT across the type and location of recruitment to allow for more direct comparisons with the SIAS sample. COUNT results showed some influence of these aspects of study design on prevalence outcomes; in particular, venue-recruitment contributed a higher sexual risk sample (more consistent with the SIAS sample) compared to festivalrecruited participants and a higher prevalence of undiagnosed HIV. While the small number of undiagnosed infections detected in COUNT limited statistical power to undertake recruitment location-specific comparisons, undiagnosed HIV prevalence was meaningfully lower among venuerecruited GBM in COUNT compared with SIAS. While adding an option for test results delivery in COUNT reflected World Health Organization (WHO) and UNAIDS guidelines (published after SIAS was implemented) that recommend participants in serological HIV surveillance be given an opportunity to learn their correct status, 41, 42 this difference in study protocol remains a potential limitation in our comparative analysis. As might be expected, men reporting a previous diagnosis tended to participate anonymously given they would receive no direct benefit from confidential participation and results delivery. While these preferences biased findings towards a low serological prevalence/high undiagnosed prevalence outcome in the confidential arm of COUNT, strongly discrepant patterns in the anonymous arm of COUNT resulted in a nonsignificant difference in HIV prevalence and a significantly lower undiagnosed prevalence in the overall COUNT sample compared with SIAS.
Conclusion
Our study provides the first data on potential changes in undiagnosed HIV among GBM in Australia and suggests a substantial decline in undiagnosed HIV in this population in Melbourne between 2008 and 2014. Global HIV prevention strategies are increasingly focused on treatment-as-prevention, with an emphasis on reducing undiagnosed HIV, timely access to treatment and viral suppression; these outcomes are also a focus of Australia's HIV strategy. Our data confirm recent modelling that shows Australia has made major in-roads in reducing undiagnosed HIV and is as close as anywhere in the world in achieving UNAIDS 90-90-90 targets.
43,44
Implications for public health
While our findings are consistent with recent reports of increases in HIV testing, comparable proportion of GBM with undiagnosed HIV in 2008 and 2014 reported recent testing histories. In the context of sustained and historically high annual HIV diagnosis rates among GBM in Australia and the potential substantial contribution of undiagnosed acute infection to transmission, 6 new testing strategies that expand the reach of high frequency testing may be required to impact the trajectory of the Australian HIV epidemic.
